2017 Innovation Grants - Professor Brendan Jenkins
New therapeutic tools
Professor Brendan Jenkins
Grant
A Novel Translational Pipeline for the Introduction of New Immune-Based Therapies Targeting Localised and Metastatic Pancreatic Ductal Adenocarcinoma
Award
Innovation Grant 2017
Institution
Hudson Institute of Medical Research
This project aims to show the preclinical efficacy of a novel series of immune-based therapies across a range of human pancreatic tumours which have been genetically screened to predict treatment responsiveness. This project also addresses the need to identify new genes that can be the target of novel therapeutic approaches.
Professor Brendan Jenkins, Hudson Institute of Medical Research
Research Reports
Click to download progress reporting on the outcomes of this research.